STAND. COM. REP. NO. 2893
RE: S.B. No. 2049
Honorable Ronald D. Kouchi
President of the Senate
Twenty-Ninth State Legislature
Regular Session of 2018
State of Hawaii
Your Committee on Ways and Means, to which was referred S.B. No. 2049 entitled:
"A BILL FOR AN ACT RELATING TO CANCER RESEARCH,"
begs leave to report as follows:
The purpose and intent of this measure is to make an appropriation to the University of Hawaii Cancer Center to determine the reasons that Hawaii has the highest incidence of liver and bile duct cancer in the nation.
Your Committee received written comments in support of this measure from the University of Hawaii Cancer Center; American Cancer Society Cancer Action Network; Democratic Party of Hawaii, Hawaiian Affairs Caucus; OCC Legislative Priorities, Democratic Party of Hawai'i; and a number of individuals.
Your Committee finds that there is an important public health need for the University of Hawaii Cancer Center to study the prevalence of liver fluke infection, aflatoxin ingestion, and intrahepatic bile duct dilation in the general population and its possible contribution to high rates of liver and bile duct cancer in Hawaii.
Your Committee has amended this measure by:
(1) Changing the appropriation to an unspecified amount;
(2) Changing the effective date to July 1, 2050, to facilitate further discussion on the measure; and
(3) Making technical nonsubstantive changes for purposes of clarity, consistency, and style.
As affirmed by the record of votes of the members of your Committee on Ways and Means that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2049, as amended herein, and recommends that it pass Third Reading in the form attached hereto as S.B. No. 2049, S.D. 1.
Respectfully submitted on behalf of the members of the Committee on Ways and Means,
DONOVAN M. DELA CRUZ, Chair